Trademark: 78103012
Word
TALIZMA
Status
Dead
Status Code
606
Status Date
Wednesday, June 4, 2003
Serial Number
78103012
Mark Type
1000
Filing Date
Wednesday, January 16, 2002
Published for Opposition
Tuesday, September 10, 2002
Abandoned Date
Wednesday, June 4, 2003
Trademark Owner History
La Jolla Pharmaceutical Company - Owner At Publication
Classifications
5 Pharmaceutical preparations for prevention and treatment of antibody-mediated diseases, namely, systemic lupus erythematosus, RH hemolytic disease of the newborn, antiphospholipid antibody syndrome, Grave's disease, myasthenia gravis, Hashimoto's thyroiditis, pemphigus, autoimmune hemolytic anemia, autoimmune thrombocytopenia purpura, antibody mediated infertility, Sjogre's syndrome, mixed connective tissue disease, glomerulonephritis and Goodpasture's syndrome
Trademark Events
Sep 9, 2003
Abandonment - No Use Statement Filed
Dec 3, 2002
Noa Mailed - Sou Required From Applicant
Sep 10, 2002
Published For Opposition
Aug 21, 2002
Notice Of Publication
Jun 3, 2002
Approved For Pub - Principal Register
Jun 3, 2002
Examiners Amendment Mailed
May 6, 2002
Non-Final Action Mailed
May 2, 2002
Assigned To Examiner
WALL STREET MINT
ICOLISEUM
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov